VPLCV Performance — ProFund VP Large-Cap Value
Data updated: 2026-08-28
VPLCV returned +7.10% year to date and +16.41% over one year to Jun 2026. Annualised returns are +12.47% over 3 years and +9.45% over 5 years. The fund trailed its US Large Value category average: $100 invested three years ago grew to $142, against $158 for the category, and to $116 over one year, against $121. Volatility over the past three years was 12.12% a year. In the 12 months to Jun 2026 the fund took in a net $3.2M, and assets reached $17.04M.
VPLCV Growth of $100
What $100 invested in ProFund VP Large-Cap Value grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | VPLCV | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $116 | $121 |
| 3 years (Jul 2023 – Jun 2026) | $142 | $158 |
| 5 years (Jul 2021 – Jun 2026) | $157 | $165 |
| Since data start (Jul 2019 – Jun 2026) | $203 | $223 |
VPLCV Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.10% |
| 1 year | +16.41% |
| 3 years (annualised) | +12.47% |
| 5 years (annualised) | +9.45% |
VPLCV Annual Returns
Calendar-year total returns of ProFund VP Large-Cap Value, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +7.10% |
| 2025 | +11.37% |
| 2024 | +10.41% |
| 2023 | +20.11% |
| 2022 | −6.82% |
| 2021 | +22.97% |
| 2020 | −0.04% |
| 2019 (Jul–Dec) | +12.09% |
VPLCV Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.4% | +2.1% | −4.7% | +5.7% | +1.8% | −0.1% | — | — | — | — | — | — |
| 2025 | +2.8% | +0.3% | −3.1% | −3.7% | +2.9% | +3.5% | +0.8% | +3.3% | +1.6% | +1.0% | +1.6% | +0.2% |
| 2024 | +0.1% | +2.9% | +4.4% | −4.4% | +2.8% | −0.8% | +4.6% | +2.8% | +1.0% | −1.4% | +5.7% | −6.9% |
| 2023 | +6.8% | −3.1% | +1.2% | +1.6% | −2.1% | +6.7% | +3.2% | −2.9% | −4.8% | −1.9% | +9.4% | +5.4% |
| 2022 | −1.8% | −1.5% | +2.8% | −5.0% | +1.5% | −8.4% | +5.8% | −3.0% | −8.6% | +11.4% | +5.9% | −4.1% |
| 2021 | −1.7% | +5.8% | +6.1% | +3.6% | +2.3% | −1.3% | +0.7% | +1.6% | −3.4% | +4.5% | −3.4% | +6.9% |
| 2020 | −2.8% | −9.6% | −15.2% | +10.6% | +3.1% | −1.1% | +3.5% | +3.4% | −2.5% | −2.2% | +12.7% | +3.3% |
| 2019 | — | — | — | — | — | — | +1.6% | −2.7% | +3.6% | +2.5% | +3.7% | +3.0% |
VPLCV Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 12.12%
- 3-year Sharpe ratio: 0.66 (vs 4.5% risk-free rate)
- Best month: +9.41% (Nov 2023)
- Worst month: −6.90% (Dec 2024)
VPLCV Fund Flows
Monthly money in and out of ProFund VP Large-Cap Value, from SEC Form N-PORT.
- 12-month net flow: $3.2M
- 12-month gross sales (incl. reinvestments): $16.6M
- Sales ÷ redemptions: 1.24×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $2.2M | $2.0M | $170K |
| May 2026 | $407K | $654K | −$247K |
| Apr 2026 | $1.1M | $183K | $949K |
| Mar 2026 | $146K | $596K | −$451K |
| Feb 2026 | $2.0M | $620K | $1.4M |
| Jan 2026 | $1.2M | $1.2M | $3K |
| Dec 2025 | $420K | $2.5M | −$2.1M |
| Nov 2025 | $3.6M | $2.0M | $1.7M |
| Oct 2025 | $2.5M | $2.3M | $209K |
| Sep 2025 | $317K | $750K | −$433K |
| Aug 2025 | $2.3M | $335K | $2.0M |
| Jul 2025 | $315K | $241K | $73K |
VPLCV Assets Under Management
Net assets of ProFund VP Large-Cap Value by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $17.04M |
| 2026-03-31 | $16.33M |
| 2025-12-31 | $15.51M |
| 2025-09-30 | $15.24M |
| 2025-06-30 | $14.68M |
| 2025-03-31 | $20.08M |
| 2024-12-31 | $16.98M |
| 2024-09-30 | $17.19M |
| 2024-06-30 | $15.26M |
| 2024-03-31 | $18.47M |
| 2023-12-31 | $20.30M |
| 2023-09-30 | $16.23M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.